BUSINESS

• MTPC Plans Entry into Global Vaccine Business Starting with a Seasonal Influenza Vaccine
  July 3, 2014

• Hospira Japan Appoints Former Mundipharma President Toyohara as Its New President
  July 3, 2014

• Sawai, MTPC Agree on Transfer of Kashima Plant to Sawai
  July 3, 2014

• Takeda Sets Up Japan Vaccine Unit Led by Ex-Sanofi R&D Head
  July 2, 2014

• Pfizer Japan to Diversify Revenue Streams to Maintain Growth in “Post-Lipitor Era”: President
  July 2, 2014

• Sumitomo Dainippon Transfers Marketing Rights to 3 Brands Including Inteban to Teikoku Seiyaku
  July 2, 2014

• Sanofi Ties Up with Japanese Bioventure for Development of Transdermal Patch Formulation of Lyxumia
  July 2, 2014

• Dr Morich’s 900 Million Yen Exec Pay Highest in Takeda
  July 1, 2014

• Sanofi, Takeda Team Up to Raise Awareness of Diabetes
  July 1, 2014

• Teijin Licenses ADA Deficiency Treatment from Sigma-Tau Pharma
  July 1, 2014

• Gilead Submits NDA for HCV Treatment Sofosbuvir in Japan
  July 1, 2014

• RaQualia, Eli Lilly of US Cease Research Collaboration for Analgesics
  July 1, 2014

• Takeda CEO Defends Millennium, Nycomed Acquisitions as “Not Failures”
  June 30, 2014

• Takeda CEO Counters Opposing Shareholders, Says Mr Weber Most Appropriate to Lead Drug Maker
  June 30, 2014

• Astellas, UCB Japan File for Cimzia for Treatment-Naïve RA Patients
  June 30, 2014

• Weber Becomes 1st Non-Japanese President of Takeda
  June 27, 2014

• Eisai Files World’s 1st NDA for Anticancer Agent Lenvatinib in Japan
  June 27, 2014

• BMKK to Begin Third-Party Investigation into Company Involvement in Sprycel Trial
  June 26, 2014

• Kyowa Pres. Eyes Excursion into Authorized Generic Territory
  June 26, 2014

• X-Linked Hypophosphatemia Treatment Improves Phosphate Metabolism in PI/II Study: Kyowa Kirin
  June 26, 2014

ページ

• « 先頭
• ‹ Prev
• …
• 560
• 561
• 562
• 563
• 564
• 565
• 566
• 567
• 568
• …
• Next ›
• 最終 »